INS and autoimmune pancreatitis: On the other hand, Masuda et al. concluded that pancreatic atrophy after treatment with GCs could be closely associated with the onset of DM in AIP patients [27], which was also Noguchi’s observation, as well as the fact that DM in patients with AIP was associated with impaired insulin secretion rather than insulin resistance in the early phase of AIP [26].